Company profile
bitrobius.com - Home
Bitrobius Genetics Ltd is a UK company with status active founded in 2020 based in North West England.
Financial period: 1 Dec 2023 to 30 Nov 2024
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
CS01 | Transaction MzQ0NDg5Njg0NmFkaXF6a2N4
Published 26 Nov 2024 09:36
AP01 | Transaction MzQ0NDA3NTI3MWFkaXF6a2N4
Published 19 Nov 2024 08:23
AA | Transaction MzQzMzk5NTg3MWFkaXF6a2N4
Published 30 Aug 2024 16:58
Company registered at Companies House
1 Sep 2023 to 31 Dec 2025
Bitrobius Genetics aims to develop cures for three important and prevalent genetic diseases: cystic fibrosis, muscular dystrophy and myotonia congenita, as well as hereditary breast cancer. We will do this using a new technology called Gentrafix, which will greatly improve the ability of DNA to repair faulty genes using a gene editing technology. It can t...
1 Aug 2021 to 31 Jan 2023
